Present and future of developmental neuropsychopharmacology

Area of Science:

• Child and adolescent psychiatry
• Developmental neuropsychopharmacology
• Mental health research

Background:

• Child psychiatry research historically lags behind adult psychiatry.
• Most mental disorders, even adult-onset, stem from abnormal neurodevelopment.
• This highlights the critical need for prevention and early intervention strategies.

Purpose of the Study:

• To advocate for prioritizing child psychiatry and developmental neuropsychopharmacology in mental health research agendas.
• To shift drug discovery targets towards younger populations to address developing brains.
• To explore novel therapeutic strategies for the critical developmental window.

Main Methods:

• Review of current challenges in developmental psychopharmacology.
• Analysis of the need for age-specific research in psychopharmacology.
• Identification of future research directions for developmental neuropsychopharmacology.

Main Results:

• Current psychopharmacology faces issues of over-prescription and limited evidence for some pediatric conditions.
• Adverse effects, including cardiometabolic risks and suicidal ideation, are significant concerns.
• A shift towards targeting developing brains is necessary for effective interventions.

Conclusions:

• Child and adolescent psychiatry requires greater research investment.
• Drug discovery must focus on interventions for developing brains, not just mature ones.
• Future research should emphasize preventative pharmacologic strategies to modify abnormal neurodevelopment.